Susan J Back1, Carolina Maya2, Kassa Darge2, Patricia T Acharya3, Carol E Barnewolt4, Jamie L Coleman5, Jonathan R Dillman6, Lynn Ansley Fordham7, Misun Hwang8, Annie Lim9, M Beth McCarville5, Marthe M Munden10, Harriet J Paltiel4, Frank M Volberg11. 1. Department of Radiology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, 34th Street and Civic Center Boulevard, Philadelphia, PA, 19104, USA. backs@email.chop.edu. 2. Department of Radiology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, 34th Street and Civic Center Boulevard, Philadelphia, PA, 19104, USA. 3. Department of Radiology, Loma Linda University Children's Hospital, Loma Linda, CA, USA. 4. Department of Radiology, Boston Children's Hospital, Harvard University, Boston, MA, USA. 5. Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN, USA. 6. Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. 7. Division of Pediatric Imaging, Department of Radiology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 8. Division of Pediatric Radiology, Johns Hopkins Hospital, Baltimore, MD, USA. 9. Radiology Department, Section of Interventional Radiology, Children's Health System Nemours, Orlando, FL, USA. 10. Department of Radiology, Brenner Children's Hospital, Wake Forest Baptist Health, Winston-Salem, NC, USA. 11. Division of Pediatric Radiology, Department of Radiology, Georgetown University, Washington, DC, USA.
Abstract
BACKGROUND: The United States Food and Drug Administration (FDA) recently approved an ultrasound (US) contrast agent for intravenous and intravesical administration in children. OBJECTIVE: Survey the usage, interest in and barriers for contrast-enhanced US among pediatric radiologists. MATERIALS AND METHODS: The Contrast-Enhanced Ultrasound Task Force of the Society for Pediatric Radiology (SPR) surveyed the membership of the SPR in January 2017 regarding their current use and opinions about contrast-enhanced US in pediatrics. RESULTS: The majority (51.1%, 166) of the 325 respondents (26.7% of 1,218) practice in either a university- or academic affiliated group. The most widely used US contrast agent was Lumason® 52.3% (23/44). While lack of expertise and training were reported barriers, all respondents who are not currently using US contrast agents are considering future use. CONCLUSION: Interest in pediatric contrast US is very high. Education and training are needed to support members who plan to adopt contrast US into practice.
BACKGROUND: The United States Food and Drug Administration (FDA) recently approved an ultrasound (US) contrast agent for intravenous and intravesical administration in children. OBJECTIVE: Survey the usage, interest in and barriers for contrast-enhanced US among pediatric radiologists. MATERIALS AND METHODS: The Contrast-Enhanced Ultrasound Task Force of the Society for Pediatric Radiology (SPR) surveyed the membership of the SPR in January 2017 regarding their current use and opinions about contrast-enhanced US in pediatrics. RESULTS: The majority (51.1%, 166) of the 325 respondents (26.7% of 1,218) practice in either a university- or academic affiliated group. The most widely used US contrast agent was Lumason® 52.3% (23/44). While lack of expertise and training were reported barriers, all respondents who are not currently using US contrast agents are considering future use. CONCLUSION: Interest in pediatric contrast US is very high. Education and training are needed to support members who plan to adopt contrast US into practice.
Authors: M Claudon; D Cosgrove; T Albrecht; L Bolondi; M Bosio; F Calliada; J-M Correas; K Darge; C Dietrich; M D'Onofrio; D H Evans; C Filice; L Greiner; K Jäger; N de Jong; E Leen; R Lencioni; D Lindsell; A Martegani; S Meairs; C Nolsøe; F Piscaglia; P Ricci; G Seidel; B Skjoldbye; L Solbiati; L Thorelius; F Tranquart; H P Weskott; T Whittingham Journal: Ultraschall Med Date: 2008-02 Impact factor: 6.548
Authors: Kassa Darge; Frederica Papadopoulou; Aikaterini Ntoulia; Dorothy I Bulas; Brian D Coley; Lynn A Fordham; Harriet J Paltiel; Beth McCarville; Frank M Volberg; David O Cosgrove; Barry B Goldberg; Stephanie R Wilson; Steven B Feinstein Journal: Pediatr Radiol Date: 2013-07-11
Authors: F Piscaglia; C Nolsøe; C F Dietrich; D O Cosgrove; O H Gilja; M Bachmann Nielsen; T Albrecht; L Barozzi; M Bertolotto; O Catalano; M Claudon; D A Clevert; J M Correas; M D'Onofrio; F M Drudi; J Eyding; M Giovannini; M Hocke; A Ignee; E M Jung; A S Klauser; N Lassau; E Leen; G Mathis; A Saftoiu; G Seidel; P S Sidhu; G ter Haar; D Timmerman; H P Weskott Journal: Ultraschall Med Date: 2011-08-26 Impact factor: 6.548
Authors: Paul S Sidhu; Vito Cantisani; Annamaria Deganello; Christoph F Dietrich; Carmina Duran; Doris Franke; Zoltan Harkanyi; Wojciech Kosiak; Vittorio Miele; Aikaterini Ntoulia; Maciej Piskunowicz; Maria E Sellars; Odd Helge Gilja Journal: Ultraschall Med Date: 2016-07-14 Impact factor: 6.548
Authors: Vasileios Rafailidis; Annamaria Deganello; Tom Watson; Paul S Sidhu; Maria E Sellars Journal: Br J Radiol Date: 2016-09-26 Impact factor: 3.039
Authors: Dean Y Huang; Gibran T Yusuf; Mohammad Daneshi; Mohammad Ali Husainy; Raymond Ramnarine; Maria E K Sellars; Paul S Sidhu Journal: Radiographics Date: 2017-03-18 Impact factor: 5.333
Authors: David G Ramirez; Mark Ciccaglione; Awaneesh K Upadhyay; Vinh T Pham; Mark A Borden; Richard K P Benninger Journal: Proc Natl Acad Sci U S A Date: 2021-10-12 Impact factor: 11.205